Strategic report Corporate governance Financial statements Financial statements Notes to the consolidated financial statements continued 14.
Property, plant and equipment Other intangible assets Machinery Vehicles, Amortisation of all intangible assets with finite useful lives is charged on a straight-line basis.
Land and and Fixtures and Projects under Customer relationships: Customer relationships represent the value attributed to the existing direct customers that the Group acquired buildings equipment equipment construction Total $m $m $m $m $m on the acquisition of subsidiaries.
The customer relationships have an average estimated useful life of 15 years 2015: 15 years.
Cost Balance at 1 January 2015 302 364 84 71 821 Product related intangibles: Product related intangibles include two types: Additions 8 6 5 66 85 a.
Product files and under-licenced products: The estimated useful life varies from five to sixteen years 2015: five to fifteen years.
In process product files: Mainly represents files acquired from Bedford and West-Ward Columbus that are not yet ready for use.
Transfers 12 24 8 44 Trade name: Trade names were mainly recognised on the acquisition of Hikma Germany GmbH Germany and Promopharm.
Translation adjustment 13 17 4 2 36 The trade name recognised on the acquisition of Hikma Germany GmbH Germany has an indefinite economic useful life.
The carrying Balance at 1 January 2016 298 360 84 90 832 value of Hikma Germany GmbH Germany trade name is $4 million 2015: $5 million.
The trade names recognised on the acquisition of Additions 8 7 6 97 118 promopharm have useful lives of 10 years.
Acquisition of subsidiaries note 43 180 144 9 125 458 Adjustments to beginning balance 8 2 10 Marketing rights and others Disposals 3 1 1 5 a.
Marketing rights: are amortised over their useful lives commencing in the year in which the rights are ready for use.
Other acquisition related: This mainly represents intangible assets recognised on the acquisition of Thymoorgan, which relate to its Translation adjustment 20 21 9 4 54 specialist manufacturing capabilities.
The estimated useful life varies from 12 years to an indefinite useful life.
The carrying value of Balance at 31 December 2016 530 539 98 192 1,359 assets with indefinite lives is $1 million 2015: $1 million.
Accumulated depreciation Software: Software intangibles mainly represent the Enterprise Resource Planning solutions that are being implemented in different Balance at 1 January 2015 64 186 54 3 307 operations across the Group in addition to other software applications.
The software has an average estimated useful life varies from three Charge for the year 11 30 9 50 to five years.
Disposals 9 7 16 Impairment 1 1 As at 31 December 2016, the Group had entered into contractual commitments for the acquisition of intangible assets of $19 million Translation adjustment 5 9 3 17 2015: $49 million.
Balance at 1 January 2016 70 198 53 4 325 Charge for the year 18 39 11 68 Adjustments to beginning balance 7 3 10 Disposals 2 2 4 Impairment note 5 10 10 Translation adjustment 4 10 5 19 Balance at 31 December 2016 84 242 57 7 390 Carrying amount At 31 December 2016 446 297 41 185 969 At 31 December 2015 228 162 31 86 507 Land is not subject to depreciation Further to Bedford Laboratories Bedford acquisition in 2014, a reduction of $8 million was made to the provisional goodwill recognised on the acquisition of Bedford as a result of the adjustment to inventory, property plant and equipment and deferred tax made prior to the end of the measurement period on 15 July 2015.
The net book value of the Groups property, plant and equipment includes an amount of $6 million 2015: $8 million in respect of assets held under finance lease.
As at 31 December 2016, the Group had pledged property, plant and equipment having a carrying value of $42 million 2015: $45 million as collateral for various long-term loans.
This amount includes both specific items around the Group and the net property, plant and equipment of the Groups businesses in Portugal, Germany and Tunisia 2015: Portugal, Germany and Tunisia.
As at 31 December 2016, the Group had entered into contractual commitments for the acquisition of property, plant and equipment amounting to $9 million 2015: $9 million.
Annual Report 2016 175 166 Hikma Pharmaceuticals plc Annual Report 2016 167
